Toggle navigation
Home
Search
Services
Blog
Contact
About
Biology of Cutaneous Aging
Braverman, Irwin M.
Yale University, New Haven, CT, United States
Search 19 grants from Irwin Braverman
Search grants from Yale University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Molecular examination of mitochondrial calcium control
Training Program in Developmental Genetics
Integrated Samples of Latin American Censuses
Assure Hit Standards for Public Health
Relevance of Chemically Induced Forestomach Neoplasms in B6C3F1 Mouse
Recently added grants:
An Interactive Technology Enhanced Coaching Intervention for Black Women with Hypertension
Personalized Statin Treatment Plan to Optimize Clinical Outcomes Using Big Data
Injectable microtissues to promote rapid host re-perfusion of ischemic tissues
Continuation of the NuMoM2b Heart Health Study
Optimization of AAV vector to deliver FVa for hemophilia with inhibitors
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Institutional National Research Service Award (T32)
Project #
5T32AG000081-07
Application #
3530156
Study Section
Aging Review Committee (AGE)
Project Start
1980-09-01
Project End
1988-06-30
Budget Start
1986-09-01
Budget End
1988-06-30
Support Year
7
Fiscal Year
1986
Total Cost
Indirect Cost
Institution
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Related projects
NIH 1986
T32 AG
Biology of Cutaneous Aging
Braverman, Irwin M. / Yale University
NIH 1985
T32 AG
Biology of Cutaneous Aging
Braverman, Irwin M. / Yale University
Publications
Johansen, J; Taft, W C; Yang, J et al.
(1985)
Inhibition of Ca2+ conductance in identified leech neurons by benzodiazepines.
Proc Natl Acad Sci U S A 82:3935-9
Comments
Be the first to comment on Irwin Braverman's grant